Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-001146
Filing Date
2025-02-21
Accepted
2025-02-21 16:27:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 24945
  Complete submission text file 0001950047-25-001146.txt   26427
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Subject) CIK: 0000318154 (see all company filings)

EIN.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37702 | Film No.: 25652349
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address
REESE DAVID M (Reporting) CIK: 0001748434 (see all company filings)

Type: 144